日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pharmacokinetic analysis of selective TRPV2 inhibitor SET2 in rats

选择性TRPV2抑制剂SET2在大鼠体内的药代动力学分析

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-13891-7
Bartosova, Linda; Doka, Gabriel; Kralova, Eva; Balis, Peter; Dulova, Ulrika; Ferenczyova, Kristina; Kovac, Andrej; Piestansky, Juraj; Rajtik, Tomas
SET
Rat
发表日期：2025
文献求助 收藏

Pleural Effusion Formation Linked to Altered Transporter Expression Involved in Alveolar Fluid Clearance: Insights From the Monocrotaline Model of Pulmonary Hypertension.

胸腔积液的形成与肺泡液清除过程中转运蛋白表达的改变有关：来自单克罗他林肺动脉高压模型的启示

期刊:Basic & Clinical Pharmacology & Toxicology
影响因子:3.3
doi:10.1111/bcpt.70096
Lelkova Katarina, Hadova Katarina, Katanova Michaela, Babiakova Jana, Kmecova Zuzana Albert, Babiak Emil, Babal Pavel, Doka Gabriel, Klimas Jan, Krenek Peter
其它
发表日期：2025
文献求助 收藏

Biomarkers for the prediction and monitoring of the antipsychotic/antidepressant-induced hepatotoxicity: study protocol

用于预测和监测抗精神病药/抗抑郁药引起的肝毒性的生物标志物：研究方案

期刊:Pharmacogenomics
影响因子:1.9
doi:10.1080/14622416.2025.2456449
Kilianova, Zuzana; Stollarova, Natalia; Pivackova, Lenka Bies; Krenek, Peter; Goboova, Maria; Rihova, Zuzana Javorova; Aziz, Evelin Karim; Kuzelicki, Natasa Karas; Doka, Gabriel; Klimas, Jan
毒理研究
神经科学
发表日期：2024
文献求助 收藏

Disease severity-related alterations of cardiac microRNAs in experimental pulmonary hypertension

实验性肺动脉高压中与疾病严重程度相关的心脏microRNA改变

期刊:Journal of Cellular and Molecular Medicine
影响因子:4.2
doi:10.1111/jcmm.15352
Kmecova, Zuzana; Veteskova, Jana; Lelkova-Zirova, Katarina; Bies Pivackova, Lenka; Doka, Gabriel; Malikova, Eva; Paulis, Ludovit; Krenek, Peter; Klimas, Jan
肺动脉高压
心血管
发表日期：2020
文献求助 收藏